| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cancer-Related Problem/Condition | |||||
| Prostate Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Erectile Dysfunction | |||||
| Prostatic Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Genital Diseases, Male | |||||
| Genital Neoplasms, Male | |||||
| Mental Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Prostatic Diseases | |||||
| Sexual and Gender Disorders | |||||
| Sexual Dysfunction, Physiological | |||||
| Sexual Dysfunctions, Psychological | |||||
| Urogenital Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| sildenafil citrate | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Sildenafil | |||||
| 6 | More general drug interventions related to this trial | ||||
| Cardiovascular Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Phosphodiesterase Inhibitors | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| Radiation Therapy Oncology Group | |||||
| National Cancer Institute (NCI) | |||||
|
